Skip to main navigation Skip to search Skip to main content

Retraction Note: Human bone marrow-derived mesenchymal stem cell-secreted exosomes overexpressing microRNA-34a ameliorate glioblastoma development via down-regulating MYCN (Cellular Oncology, (2019), 42, 6, (783-799), 10.1007/s13402-019-00461-z)

  • Bin Wang
  • , Zhong Hua Wu
  • , Ping Yang Lou
  • , Chang Chai
  • , Shuang Yin Han
  • , Jian Fang Ning
  • , Ming Li

Research output: Contribution to journal › Comment/debate › peer-review

Abstract

The Editor-in-Chief has retracted this article. After publication, the corresponding author stated that he has been unable to reproduce the targeting relationship between miR- 34a and MYCN in animal experiments. Additionally, the authors have been unable to provide documents confirming that ethics approval was obtained for this study. The Editorin- Chief therefore considers the data reported in this the article to be unreliable.The authors have not responded to correspondence regarding this retraction notice.

Original languageEnglish (US)
Pages (from-to)1207
Number of pages1
JournalCellular Oncology
Volume44
Issue number5
DOIs
StatePublished - Oct 2021

Bibliographical note

Publisher Copyright:
© International Society for Cellular Oncology 2019

Fingerprint

Dive into the research topics of 'Retraction Note: Human bone marrow-derived mesenchymal stem cell-secreted exosomes overexpressing microRNA-34a ameliorate glioblastoma development via down-regulating MYCN (Cellular Oncology, (2019), 42, 6, (783-799), 10.1007/s13402-019-00461-z)'. Together they form a unique fingerprint.

Cite this